Parikshit Somani Banned for Four Years: Trimetazidine, the Contamination Defense and the Gap at Tennis's Lower Tier

Astana. A low-tier ITF event, the kind of tournament whose results a few dozen people track on a phone screen. No packed stands, no television trucks, just net, ball, and players ranked outside the top 200 counting every point to pay for their hotel room. And a urine sampling procedure carried out as strictly as at a Grand Slam final.

The sample belonging to Parikshit Somani, a 26-year-old Indian player, was sealed, coded and sent to the laboratory. The result came back with a name the tennis world knows far too well: trimetazidine.

On Wednesday, the International Tennis Integrity Agency (ITIA) announced that an independent tribunal had banned Somani for four years, running until September 2029. The sanction does not only lock his court. It locks his right to coach, and his right to enter any event organised by the ITF, the WTA, the ATP, the Grand Slams or any national federation.

The explanation Somani offered for the positive test was painfully ordinary: cross-contamination from food. A family member was taking medication containing trimetazidine, and the substance ended up in his meal.

The panel heard it. And the panel rejected it.

The judges concluded that the food-contamination theory was "scientifically implausible", "highly speculative" and "unconvincing". Those three adjectives, placed side by side in a legal document, are not a gentle way of speaking.

People call that the failure of a career. I call it a layer of earth nobody has dug yet.

A DOUBLES PLAYER AND A NAME NOBODY REMEMBERS

For most tennis fans in Vietnam, the name Parikshit Somani barely registers on the map. He is not a singles player. He plays doubles, and his career-high doubles ranking is No. 256 in the world — a number only those inside the trade understand as both precious and fragile.

On the ITF World Tennis Tour, M15 and M25 events are the lowest rung of professional international tennis. No broadcast rights. No apparel deals. A single M15 prize pool is often only a few tens of thousands of dollars, split among dozens of players, while a week on the road — flights, hotels, food, a coach, stringing, physio — can swallow nearly everything earned.

That is why so many players ranked between 200 and 400 enter both singles and doubles. Doubles is supplementary income, an extra day of competition, a chance to pick up ranking points and slip into the qualifying draw of something bigger. Based on my own experience watching matches at low-tier ITF events in the region, those courts always feel strangely quiet. No roar from the crowd, only the bounce of the ball, the squeak of shoes on hard court, and someone talking to themselves after a lost point.

But the anti-doping procedure there is anything but quiet.

This is what many people fail to notice: an unknown player in Astana and a top star at Wimbledon answer to the same rulebook. The same prohibited list. The same detection thresholds. The same investigating body. That equality sounds beautiful on paper. But equality of obligation does not automatically come with equality of ability to defend yourself.

TRIMETAZIDINE: ONE MOLECULE, THREE FATES

Trimetazidine is not an exotic substance. It is the active ingredient in medicines used to treat angina and myocardial ischemia, widely used in many countries, cheap, and sold without prescription in some markets. In 2026, WADA added it to the prohibited list, because it can alter the metabolic efficiency of the heart muscle — an advantage deemed illegitimate in elite sport.

And since then, the same molecule has repeated itself across radically different fates.

In 2026, Chinese swimmer Sun Yang tested positive for trimetazidine and served a three-month suspension. That was when the substance had just been added to the list, and it was also the first time the sporting public realised that an ordinary heart medication could become an international sanction.

In 2026, a sample from Kamila Valieva — then 15, Russia's figure skating prodigy — was collected at the national championships and returned an adverse finding for the very same substance. The result only surfaced in February 2026, as she was dazzling at the Beijing Olympics and helping the Russian team win gold in the team event. An entire Games collapsed into crisis. It took nearly two years for the Court of Arbitration for Sport to issue its final ruling in January 2026: a four-year ban, backdated to December 2026.

And now Somani. Three athletes. Three sports. Three different sporting-political systems. One molecule.

What stands out is this: in all three cases, the defence revolved around the idea that the prohibited substance entered the body without the athlete's knowledge — through someone else's medicine, someone else's food, a mistake beyond their own control.

And in all three cases, that defence failed.

THE DEATH OF A DEFENCE

One thing that reporting often trims away needs to be said clearly: contamination is a legitimate defence, properly written into the World Anti-Doping Code. If an athlete proves the substance entered their body without fault and without negligence, the sanction can be erased entirely. If they prove no significant fault, it can be reduced.

The problem is not the rule. The problem is the burden of proof.

Within the anti-doping system, the burden of proof does not sit with the investigator — it sits on the athlete's shoulders. And the only way to win a contamination case is to prove the specific pathway by which the substance entered the body.

This is the point most fans skip when they read a sanction story. They see an athlete say "I ate food mixed with medicine" and assume it is a moving story deserving of leniency. But to a tribunal, a story is not evidence. What they need is: the family member's prescription. The drug name, dosage, batch number. The time it was taken. The time of the meal. The actual quantity of food consumed. And most importantly — pharmacokinetic data showing that the concentration in the urine sample is consistent with the contamination scenario described.

Miss any link in that chain, and the argument collapses.

In Somani's case, the ITIA said that at the August hearing, the defence did not establish the source of the alleged contamination. The panel used three phrases: scientifically implausible, highly speculative, unconvincing.

"Scientifically implausible" is the heaviest of the three. It does not say the athlete lied. It says that even if you believe the story, the story does not fit what chemistry and physiology allow. Trimetazidine is largely excreted unchanged in urine, meaning it leaves a fairly clear trace at a relatively low detection threshold. A quantity entering the body through a cross-contaminated meal, in most reasonable scenarios, would produce a concentration pattern different from what the laboratory saw.

In other words: the panel was not judging Somani's character. It was judging the physics of the story he told.

And this is where the case becomes far more interesting than a routine sanction notice.

The Valieva case and the Somani case are placed side by side in media coverage, and that juxtaposition usually carries an implication: here are two athletes using the same excuse, both rejected, both handed four years. The equivalence sounds tidy. But it hides an enormous difference in resources.

Valieva was defended by a state sporting machine, with international lawyers, experts, and an entire media apparatus behind her. She still lost. Somani walked into his hearing with an explanation about a family meal. He lost too.

Those two defeats are not the same kind of thing. One is the failure of a machine. The other is the failure of an individual standing alone.

WHAT I SEE IN ACADEMIES

I do not write reports. I excavate the memories of players who were never told.

After years spent observing youth tennis cohorts and development centres, what troubles me most has never been the big doping cases. Those come with press coverage, hearings, published sanctions. They are loud, and because they are loud they get handled.

What troubles me is the small plastic box in the team bag.

On many observation trips, I have watched young players take painkillers, anti-inflammatories, supplements, multivitamins — all poured into one unlabelled box, nobody recording dates, nobody reading the ingredient list carefully. The strength coach hands them out, parents buy them, roommates share them. Nobody asks the obvious question: what is the active ingredient in this pill, and is it on the prohibited list?

Every tennis academy is an archaeological site. Every cohort is a cultural layer. I am merely the one taking notes.

And within that cultural layer, I almost never see a proper anti-doping education session. Not a leaflet handed out for appearance's sake. A real session, where a 15-year-old is taught that if a grandparent, parent, sibling or anyone in the house is taking heart medication and leaves it on the dining table, that is an occupational hazard of their own career.

That is what Somani's sanction exposes in a way no indictment could: we teach young athletes how to hit a ball over the net, how to move their feet, how to control their breathing. We teach them very little about controlling what goes into their bodies.

An old racket can hang on an academy wall and tell the story of an era. An old blister pack of pills never gets hung anywhere. It gets thrown away, and the lesson gets thrown away with it.

THE CONTRARIAN VIEW: FOUR YEARS IS NOT THE SAME FOR EVERYONE

The most predictable reaction to this news is moral satisfaction. An athlete tests positive, offers the familiar defence, gets called speculative by a panel, receives four years. The system works. Justice is served. Next.

I am not sure it is that tidy.

A four-year ban is a nominally identical formula applied to careers of wildly different lifespans. For a doubles player ranked No. 256, four years is not a punishment — it is a termination notice.

Look at the simple arithmetic. Somani was 26 when banned. He returns at 30, after four years without competing, without coaching inside the system, without being allowed anywhere near an ITF, WTA, ATP or Grand Slam event. During those four years, a doubles player ranked 256 — someone surviving on low-tier entries and split prize money — loses his entire professional network. His doubles partner finds someone else. His coach finds another student. Tournaments fill his slot with the next man in.

When he comes back, he does not come back to his old position. He comes back to zero.

Compare that with a top player. If a top-10 player were banned for four years, it would still be a catastrophe. But that player has a name, an image, signed contracts, a system ready to welcome a return, even a media community eager to write about the comeback day.

Same sanction. Two very different levels of devastation.

None of this means Somani is innocent, and none of it means the sanction is wrong. Trimetazidine is prohibited, and an athlete is strictly responsible for everything in their body — that is a founding principle of clean sport, and I do not want to blur it.

But there is a gap between principle and reality that we rarely want to look at.

The principle says all athletes are equal before the law. Reality says your ability to prove your innocence depends on the money you have to hire a pharmacokinetics expert, to analyse a relative's medical records, to reconstruct precisely every meal in the week the sample was taken. A player ranked 256 does not have that money.

So the real question is not "did Somani lie". The real question is: when the burden of proof is placed on someone who lacks the resources to prove anything at all, is that justice, or simply a process working exactly as designed?

I do not have the answer. And I think anyone claiming a tidy answer to that question is selling us a certainty they do not possess.

CONCLUSION

The sanction will be served. By September 2029, Parikshit Somani may set foot again on a court inside the official competition system, aged 30, with a career that has to restart almost from scratch.

What remains behind that sanction is a question no tribunal has the jurisdiction to answer: what would have happened if, at 15, someone had taught him that a pack of heart medication left on the dining table at home is also part of the rules of the game?

I am still digging that layer. The next brick is still down there.